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Calretinin (CALB2) is a diagnostic and prognostic marker in malignant pleural
mesothelioma (MPM). We previously reported that calretinin expression is regulated at
the mRNA level. The presence of a medium-sized (573 nucleotide) 3′ untranslated region
(3′UTR) predicted to contain binding sites for miR-30a/b/c/d/e and miR-9 as well as an
adenine/uridine-rich element (ARE) in all three transcripts arising from the CALB2 gene,
suggests that calretinin expression is regulated via posttranscriptional mechanisms. Our
aim was to investigate the role of the CALB2-3′UTR in the posttranscriptional regulation
of calretinin expression in MPM. CALB2-3′UTR was inserted downstream of the
luciferase reporter gene using pmiRGLO vector and reporter expression was determined
after transfection into MPM cells. Targeted mutagenesis was used to generate variants
harboring mutated miR-30 family and ARE binding sites. Electrophoretic mobility shift
assay was used to test for the presence of ARE binding proteins. CALB2-3′UTR
significantly decreased luciferase activity in MPM cells. Analysis of mutation in the ARE
site revealed a further destabilization of the reporter and human antigen R (HuR) binding
to the ARE sequence was detected. The mutation of two miR-30 binding sites abolished
CALB2-3′UTR destabilization effect; a transient delivery of miR-30e-5p mimics or
anti-miR into MPM cells resulted in a significant decrease/increase of the luciferase
reporter expression and calretinin protein, respectively. Moreover, overexpression of
CALB2-3′UTR quenched the effect of miR-30e-5p mimics on calretinin protein levels,
possibly by sequestering the mimics, thereby suggesting a competitive endogenous
RNA network. Finally, by data mining we observed that expression of miR-30e-5p
was negatively correlated with the calretinin expression in a cohort of MPM patient
samples. Our data show the role of (1) adenine-uridine (AU)-binding proteins in calretinin
stabilization and (2) miR-30e-5p in the posttranscriptional negative regulation of
calretinin expression via interaction with its 3′UTR. Furthermore, our study demonstrates
a possible physiological role of calretinin’s alternatively spliced transcripts.
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INTRODUCTION
Malignant pleural mesothelioma (MPM) is an aggressive form
of cancer arising from mesothelial cells lining the pleural cavity
and is mainly resulting from the inhalation of asbestos fibers
(Porpodis et al., 2013). Calretinin, a Ca2+ binding protein,
is a diagnostic and prognostic marker for mesothelioma (Kao
et al., 2011; Linton et al., 2014; Ordóñez, 2014; Otterstrom
et al., 2014). So far, molecular mechanisms driving calretinin
expression in mesothelioma remain largely unknown. We have
recently described that the expression of calretinin is regulated
at the level of transcription by nuclear respiratory factor 1
(NRF-1) and E2F2 transcription factors (Kresoja-Rakic et al.,
2016). As the CALB2 mRNA includes a so-called medium
size (Fanourgakis et al., 2016) 3′ untranslated region (3′UTR)
(573 bp) containing an adenine/uridine-rich element (ARE)
motif as well as a microRNA (miRNAs) binding sequences, this
suggests that posttranscriptional mechanisms of regulation are
also involved.
The ARE motif is the most frequently studied cis-acting
element that plays a role in the posttranscriptional control of
gene expression by affecting mRNA stability. Its dysregulation
has also been described in cancer (Khabar, 2010). The ARE-
containing mRNAs are directly or indirectly bound by trans-
acting RNA-binding proteins (RBPs) known as adenine-uridine
(AU)-binding proteins (AUBPs), which can in turn promote
degradation, deadenylation (ARE-mediated decay—AMD) or
even stabilization of mRNA. There are 21 AUBPs implicated
in either stabilization or destabilization of targeted ARE-mRNA
(von Roretz et al., 2011). The most extensively studied AUBPs
are HuR/ELAVL1 (human antigen R, embryonic lethal abnormal
vision, Drosophila—stabilization; Ma et al., 1996; Brennan and
Steitz, 2001), TTP (tristetraprolin), and AUF (ARE/poly(U)-
binding/degradation factor 1—destabilization) (Barreau et al.,
2005).
miRNAs are small (18–22 nt) non-coding RNAs that affect
gene expression on the posttranscriptional level. miRNAs bind
to partially complementary miRNA recognition elements (MREs)
within targeted mRNA, leading to inhibition of translation or
mRNA destabilization (Krol et al., 2010). In general, there is a
global decrease of miRNA expression in MPM in concordance
with other cancer types (Lu et al., 2005; Volinia et al., 2006;
Reid, 2015). The TargetScan (Agarwal et al., 2015), miRanda
(Betel et al., 2008), and PicTar (Krek et al., 2005) databases
predict potential binding sites for miR-30a/b/c/d/e and miR-9
within the calretinin 3′UTR. Based on the analysis of 1319
differentially expressed genes, Cheng et al. (2016) identified the
miR-30 family amongst the top 20 enriched miRNA families
in mesothelioma. Furthermore, miR-30e-5p is a part of the 6-
miRNA signature shown to predict long survival in mesothelioma
patients (Kirschner et al., 2015). So far there was no study
on the biological function of the miR-30 family or AUBP in
mesothelioma.
An additional level of complexity is achieved through the
interaction (antagonistic or cooperative) between miRNA and
RBPs (von Roretz and Gallouzi, 2008; van Kouwenhove et al.,
2011). Therefore, 3′UTR can mediate posttranscriptional gene
expression regulation, acting as a platform for the individual
effect or the crosstalk between miRNA or AUBP.
An indirect evidence for a functional role of the CALB2-
3′UTR has been suggested in a study using Calb2-IRES-Cre
transgene, in which Cre recombinase was inserted into the 3′UTR
of the mouse Calb2 gene (Tasic et al., 2016), apparently disrupting
regulatory elements and leading to discrepancy between Cre
expression and endogenous calretinin expression in adult mice.
Here, using a reporter system and mutational analysis of the
predicted putative cis-regulatory sites in the CALB2-3′UTR
followed by overexpression or inhibition, we demonstrated
that miR-30e-5p is able of modulating calretinin expression.
Additionally, we show that the ARE element in the 3′UTR
stabilizes CALB2 mRNA. Furthermore, we suggest a role for
alternative transcripts of the calretinin gene, where their 3′UTRs
might compete for the pool of trans-acting factors, thus affecting
calretinin expression. All in all, this data may explain the highest
efficiency of targeting 3′ sequence for silencing calretinin (Blum
et al., 2017) which has been suggested as a potential therapeutic
strategy for epithelioid MPM (Blum and Schwaller, 2013).
MATERIALS AND METHODS
Cell Lines
Four mesothelioma cell lines were used in experiments. ACC-
MESO-4 cell line was obtained from RIKEN BioResource
Centre (Usami et al., 2006) and maintained in RPMI-1640
medium (Sigma-Aldrich) supplemented with 15% fetal calf
serum (FCS), 1% penicillin/streptomycin (P/S) and 2 mM
L-glutamine. Both ZL55 and SPC111 cell lines were established
in our lab (Schmitter et al., 1992) whereas ONE58 was obtained
from the European Collection of Cell Cultures (Salisbury, United
Kingdom; Manning et al., 1991). ZL55 cells were cultured as
described by Thurneysen et al. (2009). SPC111 and ONE58 cells
were maintained in DMEM/F12 supplemented with 15% FCS, 1%
P/S and 2 mM L-glutamine.
Generation of the CALB2-3′UTR and
Mutant Luciferase Reporters
To generate the luciferase reporter construct pmiRGLO-
CALB2-3′UTR (72800 Addgene), CALB2-3′UTR was
amplified from genomic DNA (ZL55) using the
following tailed primers: forward NheI 5′-ATTTGCTAGC
AGTGGGGACGGGGGCTGCTT-3′, and reverse SalI 5′-
ACGTGTCGACGGGTAAGTTTCCACAGCAGG-3′. The
polymerase chain reaction (PCR) was performed in a total
volume of 50 µl containing 1× Colorless Go Taq R© Flexi Buffer
(Promega), 2 mM MgCl2 solution, 0.2 mM PCR Nucleotide
Mix, 0.2 µM of each primer, 1.25 U of Go Taq R© G2 Hot Start
Polymerase (Promega) and 25 ng of genomic DNA. The sequence
of interest was amplified by means of touchdown PCR system:
denaturation at 95◦C, annealing at 60◦C/63◦C/65◦C/68◦C,
extension at 74◦C (10 cycles for each different annealing
temperature condition). Amplified CALB2-3′UTR was cloned
downstream of the Firefly luciferase coding sequence in the
pmiRGLO vector (Cat. No. 1330, Promega). The QuickChange
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Site-Directed mutagenesis kit (200518, Agilent technologies) was
employed to introduce mutations in the ARE or miR-30 sites with
the following primers: pmiRGLO-CALB2-3′UTRmtARE (74425
Addgene), 5′-ctctgttggacatagaagcccagaccatacagcgagggagctcat-3′,
5′-atgagctccctcgctgtatggtctgggcttctatgtccaacagag-3′; pmiRGLO-
CALB2-3′UTRmir30mt (74428 Addgene), 5′-cgtgctccttttctcttt
gggtttcttttatcccaaagaagagtttacagacaat-3′, 5′-attgtctgtaaactcttctttg
ggataaaagaaacccaaagagaaaaggagcacg-3′; pmiRGLO-CALB2-3′
UTRmir30dmt (74429 Addgene), 5′-ttgggtttcttttatcccaaagaagat
tatccagacaataaaatggaaaggtcctgc-3′, 5′-gcaggacctttccattttattgtctgg
ataatcttctttgggataaaagaaacccaa-3′ and, a combination of primers
above to construct pmiRGLO-CALB2-3′UTR-mir30dmt-mtARE
(74430 Addgene).
Stable and Transient Transfection, and
Luciferase Reporter Assay
To generate stable cell lines carrying pmiRGLO-CALB2-3′UTR
or empty pmiRGLO, 1 × 105 ACC-Meso-4 or ONE58 cells were
transfected with 200 ng of the corresponding plasmid and 1 µl
of Lipofectamine 2000 in six-well plate. On the following day,
geneticin-containing medium was added and replaced every 3–4
days until cells reached confluence for a further expansion.
For transient plasmid transfection, 0.8–1 × 105 cells were
seeded in 12-well plate. On the following day, 200 ng plasmid
along with 1 µl of DMRIE-C transfection reagent mixed in
800 µl of OPTIMEM, was added to the corresponding wells
and incubated for 9 h. After 48 h, transfected cells were lysed
and reporter activity was measured afterward using the Dual-
Luciferase reporter assay according to manufactures instructions
(Promega, Madison, WI, United States).
miRNA Mimic and Inhibitor Treatment
For mimics and anti-miR treatment, following mimics were used:
1 or 5 nM of has-miR-30b-5p (MSY0000420, Qiagen), has-miR-
30c-5p (MSY0000244, Qiagen), hsa-miR-9-5p (MSY0000441,
Qiagen), hsa-miR-30e-5p (Shanghai GenePharma Co., Ltd), or
10 nM or 30 nM anti-hsa-miR-30e-5p (MIN0000692, Qiagen),
respectively, was transiently delivered using Lipofectamine
RNAiMAX according to the manufacturer’s reverse transfection
protocol as previously described (Shi et al., 2012). 5 × 104
cells were then plated in 12-wells plate and whole cell
lysates were prepared after 72 h for the luciferase or protein
measurement.
Relative Gene Expression and Western
Blotting
RNA was extracted and cDNA was prepared as previously
described (Sidi et al., 2011). Relative mRNA levels were
determined by comparing the PCR cycle thresholds between
cDNA of a specific gene and histone (1Ct method) (Andre
and Felley-Bosco, 2003). Selected gene expression analysis
using Minimum Information on Quantitative Experiments
(MIQE) compliant protocols was conducted as previously
described (Bustin et al., 2009). Following genes were quantified:
HuR (5′-GGGCTATGGCTTTGTGAACTA-3′; 5′-GCGAGCA
TACGACACCTTAAT-3′); TTP (5′-GGATCCGACCCTGAT
GAATATG-3′; 5′-GAAACAGAGATGCGATTGAAGATG-3′;
Firefly luciferase (5′-GTGGTGTGCAGCGAGAATAG-3′; 5′-CG
CTCGTTGTAGATGTCGTTAG-3′); Renilla luciferase (5′-CG
TTGGCTACCCGTGATATT-3′; 5′-CTCGTCAAGAAGGCGA
TAGAAG-3′), primers detecting CALB2 alternative transcripts
are listed in Supplementary Figure 1.
miRNA expression was determined according manufacturer’s
protocols using the miRNeasy Mini Kit (Qiagen), miScript II RT
(Qiagen), miScript primer assays (Qiagen), and miScript SYBR
Green PCR Kit (Qiagen) in the 7900HT Fast Real-Time PCR
System (SDS, ABI/Perkin Elmer). Relative miRNA levels were
determined by comparing the PCR cycle thresholds between
cDNA of a specific gene and RNU-6B-2 (1Ct method).
Calretinin protein expression was analyzed as previously
described (Kresoja-Rakic et al., 2016).
Electrophoretic Mobility Shift Assay
(EMSA) for RNA–Protein Complexes
Cytosolic protein extracts were isolated using the NE-PERTM
Nuclear and Cytoplasmic Extraction Kit (78833, Pierce
Biotechnology) according to manufacturer’s instructions.
To demonstrate possible interactions of RBP and single stranded
RNA containing AUUUA pentamer, RNA-EMSA was performed
using LightShift R© Chemiluminescent RNA EMSA Kit (Pierce
Biotechnology). The binding reaction (20 µl total) contained
1× binding buffer (10 mM HEPES, pH 7.3), 20 mM KCL,
1 mM MgCl2, 1 mM DTT), 2.5% glycerol, 100 mM KCl, 2.5 µg
heparin (Sigma-Aldrich), 5 µg of cytosolic protein extract.
After 5 min incubation on ice, 40 fmol specific biotinylated
RNA oligonucleotides (5′-UCGCUGUAUGAUUUAGGCUUCU
AUG-3′) was added. For competition reactions, 200-fold excess
of either specific or unrelated unlabeled RNA oligo probes
(5′-UCCUGCUUCAACAGUGCUUGGACGGAAC-3′) were
incubated with binding reactions for 5 min prior to addition
of specific biotinylated RNA oligo probe. The reactions were
incubated for 25 min at room temperature and then separated
on a 6% polyacrylamide 0.5× Tris Borate EDTA (TBE) native
gel. After the transfer on a nylon membrane, RNA probe–protein
complex was visualized using Chemiluminescent Nucleic Acid
Detection Module Kit Module (89880, Thermo Scientific Pierce)
according to manufacturer’s protocol.
RNA–Protein Immunoprecipitation
Complete magnetic RNA-protein immunoprecipitation was
performed according to the protocol of Pierce Magnetic RNA-
Protein Pull-Down kit (Thermo Scientific, 20164) using 50 pmol
of RNA and 75 µg of native cytoplasmic protein fraction of
ACC-MESO-4 cells.
Relationship between miR-30e-5p and
Calretinin in Tumor Samples
We datamined previous studies where both calretinin
immunohistochemistry (IHC) evaluation (Kao et al., 2011)
and miR-30e-5p (Kirschner et al., 2015) had been determined
in tumor samples from mesothelioma patients who underwent
extrapleural pneumonectomy between 1994 and 2009 at Royal
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Prince Alfred and Strathfield Private Hospital, Sydney, Australia.
Correlation between calretinin and miR-30e-5p expression
was analyzed in a subset of 60 tumor samples, for which both
measurements were available (Supplementary Table 1).
Statistics
Data are expressed as mean ± standard deviation of multiple
experiments. Statistical analysis was performed using Mann–
Whitney U-tests using StatView 5.0.1 (SAS Institute) and
t-test using GraphPad. Spearman’s correlation test was used
to calretinin tumor positive cells (%) vs. miR-30e-5p relative
expression levels. Differences were considered statistically
significant at p< 0.05.
RESULTS
Calretinin 3′UTR Harbors a Functional
ARE Motif and miR-30 Sites
The calretinin gene (CALB2), located on chromosome 16, has
three different transcripts: (1) the full-length isoform 1 encoding
the 29 kDa protein—CALB2; (2) a non-coding alternatively
spliced variant—CALB2b (18); and (3) an alternatively spliced
variant giving rise to a 22k Da calretinin protein isoform—
CALB2c (18, 9) (Figure 1A; Schwaller et al., 1995). The length
of the 3′UTR is 573 and 716 nt in CALB2 and CALB2c,
respectively. The alternative transcript CALB2b contains the
same sequence of the 573 nt 3′UTR but the whole transcript is
considered as a non-coding since the use of the 5′-most supported
translation start codon introduces a premature termination
codon rendering the transcript a candidate for nonsense-
mediated mRNA decay.
To detect the presence of calretinin variants CALB2, CALB2b,
and CALB2c, real-time quantitative PCR (RT-qPCR) was
performed with cDNA from ZL55, ACC-MESO-4 and ONE58
cells using boundary-spanning primers approach (Figure 1A
and Supplementary Figure 1). The highest level of all three
transcripts was detected in ACC-MESO-4 cells followed by lower,
but still detectable, expression of all three transcripts in ZL55
cells, whereas only the full-length isoform CALB2 was detected in
ONE58 cells (Figure 1B). At the protein level, only the full-length
29 kDa calretinin was detected in all three cells lines, ACC-
MESO-4 (high-calretinin), ZL55 (intermediate calretinin), and
ONE58 (low-calretinin), as reported in a previous study (Kresoja-
Rakic et al., 2016). Similar to ONE58 cells, we detected only
the full-length transcript at low levels in SPC111 (low-calretinin
expressing) cells (data not shown). Analysis of tumor samples
confirmed that the expression profile of the three transcripts
observed in cell lines reflects splicing events that are also present
in tumors, with the full-length CALB2 being in all cases the most
abundant transcript (Figure 1C).
The complete 3′UTR sequence of the full-length calretinin
isoform CALB2, was used in further experiments (CALB2-
3′UTR). Multiple sequence alignment of CALB2-3′UTR across
100 vertebrates listed in the UCSC Genome Browser, indicated
two conserved stretches within the CALB2-3′UTR (Figure 2A).
The AREsite2 software (Fallmann et al., 2016) revealed a
FIGURE 1 | Three different calretinin transcripts are present in mesothelioma
cells. (A) The calretinin gene (CALB2) has been reported to have a normally
spliced transcript (full isoform CALB2-29 kDa) with 11 exons, and two
alternative splice variants CALB2b (non-coding RNA) and CALB2c (short
isoform 22 kDa) with skipped exon 8 and exons 8, 9, respectively. Labeled in
gray box is the 3′UTR (untranslated region) of CALB2 mRNA variants. Arrows
in blue, green, and orange, depict the positions of boundary spanning primers
used to detect the presence of calretinin transcripts. (B) RT-qPCR revealed
the presence of all three transcripts in ZL55 and ACC-MESO-4 cells whereas
only full isoform CALB2 (normal spliced transcript) and at low abundance is
detected in ONE58 cells. (C) The expression profile of all three calretinin
transcripts is detectable in a panel of mesothelioma tumors (e, epithelioid; b,
biphasic; s, sarcomatoid; n.d., not detected). Histones were used as internal
control.
putative ARE motif (AUUUA) within the first stretch, and
TargetScan7.1 software predicted two binding sites for the miR-
30 family and one for miR-9, within the second conserved stretch
(Figures 2A,B).
In order to test its functionality, CALB2-3′UTR was inserted
downstream of the Firefly luciferase reporter gene (pmiRGLO
vector) and transiently transfected into ONE58 cells (Figure 2C).
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FIGURE 2 | Calretinin 3′UTR contains a stabilizing and destabilizing elements. (A) Multiple species alignment of calretinin 3′UTR using UCSC Genome Browser
revealed two conserved stretches. (B) Complete calretinin 3′UTR sequence 573 nt (CALB2-3′UTR) with the predicted putative cis-regulatory elements: an
adenine/uridine-rich motif (ARE) (red), miR-30a/b/c/d/e (red), miR-9 (blue) binding sites and a poly-A site (PAS) (green). (C) 573-nt CALB2-3′UTR was inserted
downstream of the luciferase reporter in the pmiRGLO reporter plasmid. Four additional luciferase reporter constructs carrying mutations in either ARE and/or
miR-30 binding sites were generated and their activity was tested in ONE58 cells. (D) Insertion of CALB2-3′UTR significantly downregulated luciferase expression
when compared to the vector pmiRGLO alone. Mutation of the ARE-motif further downregulated reporter expression, whereas the double mutation of miR-30
binding sites abolished the downregulatory effect of the calretinin 3′UTR. FLU—Firefly Luciferase Units. The empty vector pmiRGLO plasmid expression was
arbitrarily set to 100% and the reporter activity of the mutants was expressed as a percentage of the wild-type construct. Mean ± SD, n = 8; ∗p < 0.05; ∗∗p < 0.01;
∗∗∗p < 0.005 using Mann–Whitney U-test.
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Insertion of the CALB2-3′UTR led to 40% (p= 0.0012) decreased
expression of Firefly luciferase when compared to the empty
vector (pmiRGLO), indicating that the calretinin 3′UTR conveys
a downregulatory effect (Figure 2D). We then generated an
additional four constructs harboring mutations of the consensus
sequence for the predicted ARE motif and miR-30 binding sites
and transiently transfected all variants into ONE58 cells to test for
their effects on luciferase expression (Figures 2C,D). Mutation
of the predicted ARE motif induced an even further significant
decrease of 20% (p = 0.0055), indicating that the ARE site binds
to a stabilizing factor. In contrast, mutation of both miR-30
binding sites restored the expression of the luciferase reporter
to the level of the empty vector. This downregulatory effect is
possibly conveyed through the second miR-30 binding site alone.
Despite a predicted miR-9 binding site, mimics treatment did
not exert downregulatory effect on the reporter or calretinin
expression (Supplementary Figure 2) thus excluding this miR
for further mutational analysis. Taken together, our data indicate
that the 3′UTR of the CALB2 mRNA contains multiple elements
contributing to posttranscriptional regulation and control of
calretinin protein levels.
Specific Binding of a Protein to the
25 nt-Sequence Containing ARE-Motif
Having observed that the ARE motif in the calretinin 3′UTR
is functional, we investigated the possible interaction between
this site and a potential stabilizing trans-acting factor. Indeed,
investigation of the optimal secondary structure of the CALB2-
3′UTR sequence (317 nt; 1152—1469 nt) using the RNAfold
prediction tool (Gruber et al., 2008), revealed a secondary
structure in which the ARE site forms a bulge and thus might be
accessible to an interactor. The reason for using a stretch of 317 nt
containing the predicted regulatory sequences was to increase
accuracy and to provide a better overview (Hofacker, 2009).
Replacing the AUUUA with GUCUG results in a mutated ARE
motif paired in a newly formed secondary structure predicted
to be less likely to be accessible for putative interacting protein
(Supplementary Figure 3).
We then employed a biochemical approach using
electrophoretic mobility shift assay to demonstrate the
specific interaction between a 25 nt RNA containing the
ARE motif (UCGCUGUAUGAUUUAGGCUUCUAUG) and
a cytosolic extract containing RBPs (Figure 3A). Incubation
of the biotin-labeled 25 nt RNA with a cytosolic protein
extract of ACC-MESO-4, ZL55, and SPC111 cells showed a
protein–RNA complex formation (Figure 3A, lanes 2–4). To
further confirm the specificity of the RNA–protein interaction,
competing reactions were performed using a 200-fold excess of
the identical 25 nt unlabeled sequence RNA (specific competitor)
or unlabeled-unrelated RNA-oligo (unspecific competitor).
Addition of the specific competitor decreased the detectable
RNA–protein complex (Figure 3A, lanes 5–7), whereas the
excess of the non-specific competitor did not outcompete the
biotin–RNA–protein complex (Figure 3A, lanes 8–10). The
presence of the additional lower bands in the lanes 9 and 10
are assumed to be different secondary structures formed by the
biotin-RNA oligo.
Since the mutational reporter analysis had identified the ARE
motif as a stabilizing element, we quantified the expression
of HuR (stabilizer) along with TTP (destabilizer) across 10
mesothelioma cell lines and observed that HuR is abundantly
expressed in all tested cells lines and 5- to 50-fold enriched
compared to TTP (Figure 3B). We confirmed overexpression of
HuR in mesothelioma compared to normal pleura along with a
low TTP/HuR ratio by investigating microarray data (Gordon
et al., 2005). In addition, a 25 nt-biotinylated RNA with an ARE
motif, but not the mutated RNA oligo or an unspecific sequence,
pulled-down HuR (Figure 3C). These results demonstrated that
some of the mostly studied AUBP (HuR, TTP) are expressed in
mesothelioma cells and that the 25 nt-fragment of CALB2-3′UTR
harboring the ARE element binds HuR.
miR-30e-5p Downregulates Calretinin
Protein Expression
The observation that the double miR-30 mutant construct
(pmiRGLO-CALB2-3′UTR-mir30-dmt) abolished the
downregulatory effect mediated by CALB2-3′UTR, led us
to identify the critical miR-30 member conveying this effect.
Computational analysis predicted that only the miR-30a/b/c/d/e-
5p arm is assumed to target CALB2 mRNA. Quantitative
expression analysis showed that miR-30b/c/d/e (5p-arm) are
abundantly expressed in ZL55, ONE58, ACC-MESO-4 cells
(Figure 4A). Interestingly, unlike the other miR-30 members
where the 3p arm was almost absent, both the miR-30e-5p and
-3p arms were expressed in ZL55, ONE58, ACC-MESO-4 cells.
miRNA-5p and -3p arms originate from the same pre-miRNA
but have a different sequence. Both could become functional
miRNA either targeting different mRNA or accomplish a
synergistic effect on the same mRNA, but at different sites (Mitra
et al., 2015).
ONE58 cells stably expressing Firefly luciferase-CALB2-
3′UTR, were transiently transfected with 1 and 5 nM of miR-
30b/c/e-5p mimetic treatment (Supplementary Figure 4). Of all
tested mimics, 5 nM miR-30e-5p lead to ∼60% downregulation
of luciferase expression from the CALB2-3′UTR reporter
(p = 0.0039) when compared with the negative control mimics
(Figure 4B). Calretinin protein levels were also decreased
after addition of miR-30e-5p in a concentration-dependent
manner, i.e., a larger effect with 5 nM mimics (Figure 4B).
Furthermore, anti-miR-mediated miR-30e-5p inhibition caused
a moderate but still significant upregulation of the reporter-
CALB2-3′UTR as well as an increase of calretinin protein
levels (Figure 4C). Similar results were also observed in ACC-
MESO-4 cells where the treatment with 5 nM of miR-30e-5p
mimetic resulted in ∼50% decrease (p = 0.0039) of the reporter
expression and in calretinin protein expression (Supplementary
Figure 5).
As we demonstrated that the miR-30e-5p was capable to
directly regulate calretinin expression, we investigated whether
miR-30e-5p expression correlated with calretinin expression,
determined by immunohistochemistry scoring of mesothelioma
tissue samples. In a pool of 60 mesothelioma tumor samples,
calretinin expression versus miR-30e-5p expression showed
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FIGURE 3 | 25 nt RNA oligo containing ARE-motif binds a protein from cytosolic extract of mesothelioma cell lines. (A) EMSA assay demonstrating that the 25-nt
RNA oligo containing the ARE element binds a protein present in cytosolic protein extracts of ACC-MESO-4, SPC111, and ZL55 cells (lanes 2–4). The complex is
diminished in the presence of a 200-folds excess of the same unlabeled probe (lanes 5–7), but not outcompeted in a 200-folds excess of the unrelated unlabeled
probe (lanes 8–10). (B) Quantification of two AU-binding proteins, HuR and TTP, across different mesothelioma cell lines, using histones as an internal control. Levels
are shown relative to the TTP in MSTO-211H cells according to the –11Ct method. (C) Western blot detection of HuR following RNA–protein pull-down assay that
was carried out using 75 µg of cytosolic proteins with 50 pmol of desthiobiotin-RNA used in EMSA assay.
a weak, but significant negative correlation (Figure 4D).
Altogether, these findings demonstrated an involvement of miR-
30e-5p in negatively regulating calretinin expression.
Calretinin 3′UTR Acts as Competitive
Endogenous RNA
According to the so called ceRNA (competitive endogenous
RNA) hypothesis, all types of RNA transcripts (coding and
non-coding) carrying the same MRE potentially compete for
the same miRNA pool therefore acting as natural miRNA
sponges (Salmena et al., 2011). Beside miRNA, transcripts
may also compete for binding to different RBPs adding
yet another level of complexity (Tay et al., 2014). When
ONE58 cells stably transfected with empty vector (ONE58-EV-
pmiRGLO) or the CALB2-3′UTR construct (ONE58-CALB2-
3′UTR) were transiently transfected with miR-30e-5p (∼130-
fold more abundant compared to the endogenous miR-30e-5p
pool), downregulation of calretinin expression was observed
only in ONE58 empty vector expressing cells, suggesting that
the constant exogenous overexpression of CALB2-3′UTR could
sequester miR-30e-5p mimics (Figure 5A). Indeed, in ONE58
cell line stably overexpressing the CALB2-3′UTR, exogenous
CALB2-3′UTR levels are ∼580-fold higher (estimated by Firefly
luciferase vs. CALB2 mRNA) compared to the endogenous
CALB2 mRNA level. In contrast, when anti-miR-30e-5p was
transiently delivered, increase of calretinin protein levels was
observed only in ONE58-CALB2-3′UTR and not in ONE58-EV-
pmiRGLO cells (Figure 5B). Based on our data, we suggest a
model in which the CALB2-3′UTR might act as a competitor via
sequestration of miR-30e-5p thereby decreasing its interaction
with the protein coding CALB2 mRNA isoform (Figure 5C).
Indeed, ONE58 cells only express low amounts of the full-
length isoform 29 kDa calretinin (CALB2) and not the splice
variants. In the situation of stable and strong overexpression of
CALB2-3′UTR in ONE58 cells, delivery of miR-30e-5p mimics
does not repress the expression of calretinin most likely due
to the exogenous CALB2-3′UTRs which compete to bind the
delivered miR-30e-5p and thus possibly acts as a molecular
sponge. In contrast, when the same ONE58-CALB2-3′UTR cells
were transfected with anti-miR-30e-5p, calretinin expression was
increased (but not in ONE58-empty vector expressing cells),
most likely due to repression of miR-30e-5p, which was exerted
by both, the presence of exogenous CALB2-3′UTR and anti-miR-
30e-5p treatment.
DISCUSSION
In a previous study we demonstrated a strong positive
correlation between calretinin mRNA and protein levels in
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FIGURE 4 | Members of miR-30 family are abundantly expressed in mesothelioma cell lines and miR-30e-5p regulates calretinin expression. (A) miR-30e-5p mimic
treatment significantly repressed reporter expression in ONE58 cells stable expressing reporter-CALB2-3′UTR along with downregulation of calretinin protein levels.
Mean ± SD, n = 6; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.005 using Mann–Whitney U-test. (B) Depletion of miR-30e-5p by anti-miR-30e-5p increased the reporter
expression as well as calretinin protein levels. Mean ± SD, n = 3; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.005 using t-test. (C) Quantitative RT-PCR analysis of miR-30
family members and miR-9 in three mesothelioma cell lines using as RNU-6B-2 as a reference gene. Levels are shown relative to the miR-30d-5p in ZL55 cells
according to the –11Ct method. ∗p < 0.005. (D) Weak negative correlation between calretinin expression (IHC) and miR-30e-5p in a cohort of 60 human
mesothelioma samples. Spearman’s correlation.
mesothelioma cell lines (Kresoja-Rakic et al., 2016) and
demonstrated NRF-1 and E2F2 to act as transcription factors
regulating calretinin expression. In this study, we determined that
calretinin expression is additionally regulated in mesothelioma
cells through a posttranscriptional mechanism mediated by
the 3′UTR. We determined that the CALB2-3′UTR contains
two functional elements—a stabilizing ARE motif, and two
destabilizing miR-binding sites; the identified miR-30e-5p site
was shown to negatively regulate calretinin expression. Moreover,
we propose a physiological relevance for the CALB2 alternative
spliced transcripts by their function within a ceRNA network.
3′UTRs play a functional role in the posttranscriptional
regulation of mRNA, as the 3′UTR can modulate stability, drive
subcellular localization and control translational efficiency of
mRNA (Mayr, 2016). Since the 3′UTRs of all three CALB2
transcripts contain a common 573-nt stretch, we used this region
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FIGURE 5 | Overexpression of calretinin 3′UTR competes with trans-regulatory factors and reveals a possible ceRNA network in regulation of calretinin expression.
(A) Exogenous overexpression of CALB2-3′UTR abolishes the effect of miR-30e-5p on calretinin expression in ONE58 cells. (B) Inhibition of miR-30e-5p using
anti-miR-30e-5p increased calretinin expression in ONE58 cells stably overexpressing CALB2-3′UTR. (C) Model of ceRNA network created by introducing
exogenous CALB2-3′UTR in ONE58 cell. ONE58 cell overexpress 580-times more of calretinin 3′UTR (blue) compared to endogenous calretinin mRNA and twofold
more of HuR than TTP (orange). Upon miR-30-5p mimetic treatment (red) no change is observed on calretinin protein levels due to exogenous CALB2-3′UTR that
sponges miR-30e-5p. The effect of anti-miR-30e-5p (green) is observed in ONE58 cells with exogenous CALB2-3′UTR.
for further functional analysis. Employing a reporter plasmid
assay, where the 573-nt stretch of the CALB2-3′UTR was inserted
downstream of the Firefly luciferase reporter, we observed
that CALB2-3′UTR affected the reporter mRNA stability, as it
downregulated the reporter expression in mesothelioma cells.
mRNA stability and therefore mRNA abundance in a cell
is controlled by the best studied ARE cis-acting elements and
by miRNA-binding sites. The core of the ARE sequence is the
pentameric motif AUUUA. The ARE motifs exert their function
(stabilization or destabilization) by interaction with different
ARE-binding proteins (AUBP). Since the mutational approach
revealed a stabilization element in the ARE site and we detected
HuR, an mRNA stabilizing protein (Brennan and Steitz, 2001), in
the ARE-sequence pull-down we propose that HuR is a potential
CALB2 regulator. There are several mechanisms through which
HuR exerts its stabilization effect. For example, it has been
proposed that HuR confers stabilization to mRNA by its ability
to outcompete with either destabilizing AUBP (Tiedje et al.,
2012) or miRNAs (Bhattacharyya et al., 2006; Srikantan et al.,
2012). It would be interesting to test whether silencing HuR
in cells expressing CALB2-3′UTR would increase the effects of
miR-30e on reporter expression. HuR has been reported to be
overexpressed in mesothelioma and HuR cytoplasmic expression
significantly correlated with a poor outcome in mesothelioma
patients (Stoppoloni et al., 2008). Since a decrease, and not an
increase, in calretinin expression is associated with the poorest
overall survival, this may suggest that, if it is indeed HuR
that stabilizes calretinin mRNA, it competes to bind other
tumor progression-associated targets. In fact, in mesothelioma,
HuR cytoplasmic expression is correlated with Cyclooxygenase-2
(COX-2) (Stoppoloni et al., 2008), a gene that bears 14 ARE
(Sheng et al., 2000). In our panel of six mesothelioma cell lines
and by data mining, we observed that HuR was highly expressed
and more abundant compared to TTP (destabilizer), supporting
that HuR might potentially outcompete the binding of TTP
resulting in stabilization of CALB2 mRNA, since both are able
to bind to the same ARE sequence.
The second cis-acting element that we found to be functional
within CALB2-3′UTR are destabilizing miRNA-binding sites.
CALB2 mRNA was found to interact with Argonaute-1 (AGO1),
a protein that is the part of the RNA-induced silencing
complex (RISC), which executes the function of miRNA
(Li et al., 2014; Jha et al., 2015) indicating that calretinin
transcripts are indeed regulated by miRNA. Utilizing several
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prediction algorithms, miR-30 family members were identified as
potential candidates targeting calretinin mRNA; overexpression
or inhibition experiments revealed that only miR-30e-5p is able to
modulate calretinin protein levels through the calretinin 3′UTR.
The miR-30 family includes five members, miR-30a through miR-
30e and is evolutionary well conserved. In mesothelioma, high
expression of miR-30e-5p has been associated with the epithelioid
histopathological subtype, which is generally associated with
better prognosis (Busacca et al., 2010). However, upregulation
of miR-30e-5p along with other miRNA forms the six-miRNA
signature that predicts poorest survival of MPM patients
(Kirschner et al., 2015) and this fits with low calretinin levels
in epithelioid histotype patients associated with worse outcome
(Kao et al., 2011; Otterstrom et al., 2014). Data mining TCGA
database revealed that miR-30e-3p and -5p are significantly
upregulated in cluster 1, which one of the three clusters obtained
based on a consensus non-negative matrix factorization (NMF)
clustering method of the 647 most variable miRs (Broad Institute
TCGA Genome Data Analysis Center, 2016). In the same
cluster miR-31-5p is significantly downregulated consistent with
signature findings (Kirschner et al., 2015).
The identification of both positive and negative regulatory
elements within CALB2-3′UTR suggests a possible interplay
between AUBP and miRNA, adding another level of complexity
in regulating calretinin expression, which would help
understanding why even in epithelioid MPM not all cells
are calretinin-positive (Kao et al., 2011). Different RNA-binding
factors can target the same mRNA at different sites or competing
for the same site, in a cooperative or antagonistic fashion that
depends on their expression levels, localization in the cells or
binding affinity (Vislovukh et al., 2014). Various miRNAs may act
together with AUBP on the same 3′UTR and may cause reduced
RNA stability and/or translation (Jing et al., 2005). For instance,
it has been described that the RBP Pumilio-1 (PUM1) alters the
secondary structure of target mRNA and thus allowing miR-221
and miR-22 to access the target sites (Kedde et al., 2010). In
another example, Dicer and Argonaut (recruited by miR-16)
along with TTP are required for ARE-mediated mRNA decoy of
tumor necrosis factor alpha (TNFα) (Jing et al., 2005).
The presence of the non-coding alternative spliced calretinin
transcripts suggests a potential physiological role of these
transcripts, exerted through their 3′UTR. Alternative mRNA
calretinin transcripts (CALB2b and CALB2c) had been
previously reported in different colon carcinoma cell lines
(Schwaller et al., 1995) and in mesenchymal tissue of rat embryos
(Schwaller et al., 1995). Almost all multi-exon genes can undergo
alternative splicing (Pan et al., 2008). Alternative splicing is a
tightly regulated process that contributes to transcriptome and
proteome diversity, and has been suggested to be important
in developmental stages (Revil et al., 2010). Relatively high
abundance of all three transcripts was detected in ACC-MESO-4
cells (high calretinin protein levels), whereas only low abundance
of the normally spliced 29-kDa isoform was detected in ONE58
cells (low calretinin protein levels). The same profile of CALB2
transcripts expression was observed in tumors, indicating that
alternative splicing is not a cell culture artifact. We suggest
that the expression of the alternative transcripts may be useful
to protect the full-length transcript from 3′UTR mediated
degradation. Indeed, when using exogenous expression of
CALB2-3′UTR, we increased ∼580-fold the 3′UTR sequence
compared to the endogenous CALB2 transcripts, therefore likely
contributing to the modulation of miR-30e-5p or anti-miR-30e-
5p treatment effect in ONE58 cells. This observation led to the
hypothesis that in physiological conditions, CALB2 alternative
transcripts might have their role exerted through their 3′UTR
by creating a ceRNA network in which they compete to bind
miR-30e-5p protecting the protein-coding CALB2 transcript.
Along this line of thinking, it would be interesting to investigate
whether other genes sharing the same miR-30e binding site
are protected from miRNA-30e-driven downregulation and
our data open a new avenue of investigation in that direction.
Altogether, our study is providing evidence for the importance
and the functionality of the CALB2-3′UTR in regulating
calretinin expression. Indeed, our data show the role of (1)
AUBPs in calretinin stabilization and (2) miR-30e-5p in the
posttranscriptional negative regulation of calretinin expression
via interaction with its 3′UTR. These results may provide a
rationale why targeting 3′UTR sequence for silencing calretinin,
a suggested therapeutic approach for epithelioid MPM, is more
efficient compared to targeting translated regions (Blum et al.,
2017).
Furthermore, our study demonstrates a possible physiological
role of calretinin’s alternatively spliced transcripts.
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